Clinical trial
Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose…
NCT00030719 · University of Leicester, Other · Unknown status
Key facts
| NCT number | NCT00030719 |
|---|---|
| Title | Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma |
| Official title | High Risk Neuroblastoma Study 1 Of Siop-Europe |
| Lead sponsor | University of Leicester, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, monoclonal antibody Ch14.18, busulfan, carboplatin, cyclophosphamide, etoposide, isotretinoin, melphalan, vincristine sulfate, bone marrow ablation with stem cell support and 3 more |
| Enrollment | 175 |
| Start date | Dec 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 24, 2014 |
| Countries | Austria, Belgium, Denmark, France, Ireland, Israel, Italy, Norway, Portugal, Spain, Sweden, Switzerland and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: